Effects of PlayStation®VR on the HRQOL in Stroke Patients Undergoing Inpatient Rehabilitation
1 other identifier
interventional
80
1 country
1
Brief Summary
Compared to conventional rehabilitation therapy, the full-immersive commercial game (CG) system, in the form of available video game, could safely provide more positive effect on health-related quality of life (HRQOL) and motor function in post-stroke patients. The study aims to perform the research from 2019/7/1 to 2021/6/30 and enrolls a total of 80 participants. Stroke participants are recruited from the rehabilitation ward of CGMH hospital. The inclusion criteria are (a) first-time unilateral cerebral stroke, (b) stroke onset less or equal to 1 year, (c) admission to the rehabilitation ward, (d) ages 20-80 years, (e) spasticity of paretic arm ≤ grade 2 in the Modified Ashworth Scale, and (f) no active medical problems such as fever, pneumonia, or scabies. The exclusion criteria are (a) brainstem or cerebellar stroke, (b) epilepsy history, including photosensitive epilepsy, (c) previous or active heart diseases, such as myocardial infarction or angina, (d) visuospatial problems related to stroke, such as hemianopia or hemineglect, (e) paretic upper limb reaches Brunnstrom recovery stage VI, (f) severe aphasia, (g) severe cognitive impairment, and (h) poor cooperation with assessments. All participants are randomly allocated to study group and control group. Participants in the control group receive conventional rehabilitation therapy over 50 minutes on weekdays. Participants in the study group receive conventional rehabilitation therapy over 50 minutes on weekdays and 7 sessions (flexible schedule in different day) of PlayStation®VR of 20 minutes each in the main 16-day study period. Pre-intervention, post-intervention, and 3-month follow-up HRQOL will be assessed by the Stroke Impact Scale 3.0. Motricity Index and Fugl-Meyer Assessment, Functional Independence Measure, and arm movement ratio will also be checked before intervention, after intervention, and at 3-month follow-up. The safety outcome, intervention-related adverse events or any serious adverse events, during study period will be recorded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Jul 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 29, 2019
CompletedFirst Submitted
Initial submission to the registry
June 16, 2020
CompletedFirst Posted
Study publicly available on registry
June 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedJune 22, 2020
June 1, 2020
1.9 years
June 16, 2020
June 19, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Stroke Impact Scale (SIS) 3.0 Questionnaire
Health-Related Quality of Life
Baseline (Pre-intervention at 2 days after enrollment)
Post-Intervention Change of Stroke Impact Scale (SIS) 3.0 Questionnaire
Post-intervention Health-Related Quality of Life
Change from baseline SIS scores at 18 days after enrollment
3-Month Follow-Up Change of Stroke Impact Scale (SIS) 3.0 Questionnaire
3-month follow-up Health-Related Quality of Life
Change from baseline SIS scores at 92 days after enrollment
Post-Intervention of Adverse Events or SAE
Proportion of intervention-related adverse events or SAE
16 days
Secondary Outcomes (12)
Motricity Index (MI) Upper Extremity Test
Baseline (Pre-intervention) at 2 days after enrollment
Post-Intervention Change of Motricity Index (MI) Upper Extremity Test
Change from baseline MI scores at 18 days after enrollment
3-Month Follow-Up Change of Motricity Index (MI) Upper Extremity Test
Change from baseline MI scores at 92 days after enrollment
Fugl-Meyer Assessment for Upper Extremity (FMA-UE)
Baseline (Pre-intervention) at 2 days after enrollment
Post-Intervention Change of Fugl-Meyer Assessment for Upper Extremity (FMA-UE)
Change from baseline FMA-UE scores at 18 days after enrollment
- +7 more secondary outcomes
Study Arms (2)
Study group
EXPERIMENTALParticipants in the study group receive conventional rehabilitation therapy over 50 minutes on weekdays and 7 sessions (flexible schedule in different day) of PlayStation®VR of 20 minutes each in the main 16-day study period.
Control group
NO INTERVENTIONParticipants in the control group receive conventional rehabilitation therapy over 50 minutes on weekdays.
Interventions
Participants in the study group receive conventional rehabilitation therapy over 50 minutes on weekdays and 7 sessions (flexible schedule in different day) of PlayStation®VR of 20 minutes each in the main 16-day study period.
Eligibility Criteria
You may qualify if:
- first-time unilateral cerebral stroke
- stroke onset less or equal to 1 year
- admission to the rehabilitation ward
- ages 20-80 years
- spasticity of paretic arm ≤ grade 2 in the Modified Ashworth Scale
- no active medical problems such as fever, pneumonia, or scabies
You may not qualify if:
- brainstem or cerebellar stroke
- epilepsy history, including photosensitive epilepsy
- previous or active heart diseases, such as myocardial infarction or angina
- visuospatial problems related to stroke, such as hemianopia or hemineglect
- paretic upper limb reaches Brunnstrom recovery stage VI
- severe aphasia
- severe cognitive impairment
- poor cooperation with assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chiayi Chang Gung Memorial Hospital
Pozi, 613, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chien-Min Chen, MD
Chang Gung Memorial Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Pre-intervention, post-intervention, and 3-month follow-up HRQOL will be assessed by the Stroke Impact Scale (SIS) 3.0. Motricity Index (MI) and Fugl-Meyer Assessment (FMA), Functional Independence Measure (FIM), and arm movement ratio (AMR) will also be checked before intervention, after intervention, and at 3-month follow-up. One blinded occupational therapist will evaluate the outcomes.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 16, 2020
First Posted
June 22, 2020
Study Start
July 29, 2019
Primary Completion
June 30, 2021
Study Completion
June 30, 2021
Last Updated
June 22, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share